The Artificial intelligence/AI in drug discovery Market is projected to reach USD 4.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 45.7%…
New York, June 23, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Artificial Intelligence in Drug Discovery Market by Offering, Technology, Application, End User - Global Forecasts" - https://www.reportlinker.com/p05828730/?utm_source=GNW On the other hand, the inadequate availability of skilled labor is key factor restraining the market growt at certain extent over the forecast period. .
Services segment is estimated to hold the major share in 2022 and also expected to grow at the highest over the forecast periodOn the basis of offering, the AI in drug discovery market is bifurcated into software and services. the services segment expected to account for the largest market share of the global AI in drug discovery services market in 2022, and expected to grow fastest CAGR during the forecast period. The advantages and benefits associated with these services and the strong demand for AI services among end users are the key factors for thegrowth of this segment.
Machine learning technology segment accounted for the largest share of the global AI in drug discovery marketOn the basis of technology, the AI in drug discovery market is segmented into machine learning and other technologies.The machine learning segment accounted for the largest share of the global market in 2021 and expected to grow at the highest CAGR during the forecast period.
High adoption of machine learning technology among CRO, pharmaceutical and biotechnology companies and capability of these technologies to extract insights from data sets, which helps accelerate the drug discovery process are some of the factors supporting the market growth of this segment.
Pharmaceutical & biotechnology companies segment expectd to hold the largest share of the market in 2022On the basis of end user, the AI in drug discovery market is divided into pharmaceutical & biotechnology companies, CROs, and research centers and academic & government institutes.In 2021, the pharmaceutical & biotechnology companies segment accounted for the largest share of the AI in drug discovery market.
On the other hand, research centers and academic & government institutes are expected to witness the highest CAGR during the forecast period. The strong demand for AI-based tools in making the entire drug discovery process more time and cost-efficient is the key growth factor of pharmaceutical and biotechnology end-user segment.
North America to dominate the AI in drug discovery market in 2021The global AI in the drug discovery market is segmented into four major regions, namely, North America, Europe, APAC, and the Rest of the World.In 2021, North America accounted for the largest and the fastest-growing regional market for AI in drug discovery.
North America, which comprises the US, Canada, and Mexico, forms the largest market for AI in drug discovery.These countries have been early adopters of AI technology in drug discovery and development.
Presence of key established players, well-established pharmaceutical and biotechnology industry, and high focus on R&D & substantial investment are some of the major factors responsible for the large share and high growth rate of this market.
Breakdown of supply-side primary interviews, by company type, designation, and region: By Company Type: Tier 1 (31%), Tier 2 (28%), and Tier 3 (41%) By Designation: C-level (31%), Director-level (25%), and Others (44%) By Region: North America (45%), Europe (20%), Asia Pacific (28%), and RoW (7%)
Prominent players in this market are NVIDIA Corporation (US), Microsoft Corporation (US), Google (US), Exscientia (UK), Schrdinger (US), Atomwise, Inc. (US), BenevolentAI (UK), NuMedii (US), BERG LLC (US), Cloud Pharmaceuticals (US), Insilico Medicine (US), Cyclica (Canada), Deep Genomics (Canada), IBM (US), BIOAGE (US), Valo Health (US), Envisagenics (US), twoXAR (US), Owkin, Inc. (US), XtalPi (US), Verge Genomics (US), Biovista (US), Evaxion Biotech (Denmark), Iktos (France), Standigm (South Korea), and BenchSci (Canada). Players adopted organic as well as inorganic growth strategies such as product upgrades, collaborations, agreements, partnerships, and acquisitions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
Research Coverage The report studies the AI in drug discovery market based on offering, technology, application, end user, and region The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total AI in drug discovery market The report forecasts the revenue of market segments with respect to five major regions
Key Benefits of Buying the Report:The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments.This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies.
The report also helps stakeholders understand the pulse of the AI in drug discovery market and provides them information on key market drivers, restraints, challenges, and opportunities.Read the full report: https://www.reportlinker.com/p05828730/?utm_source=GNW
About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
- Impact of Artificial Intelligence (AI) on Media and Creative Industries - EDMO - March 1st, 2025 [March 1st, 2025]
- 1 Artificial Intelligence (AI) Stock That Could Be Bigger Than Nvidia in 5 Years - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? - Nature.com - March 1st, 2025 [March 1st, 2025]
- Applications of Artificial Intelligence in Medical Education: A Systematic Review - Cureus - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - AOL - March 1st, 2025 [March 1st, 2025]
- Federal Executive Forum Artificial Intelligence Strategies in Government Progress and Best Practices 2025 - Federal News Network - March 1st, 2025 [March 1st, 2025]
- Introduction to Artificial Intelligence for General Surgeons: A Narrative Review - Cureus - March 1st, 2025 [March 1st, 2025]
- How is Artificial Intelligence Affecting Health Care? - Workers Comp Forum - March 1st, 2025 [March 1st, 2025]
- 1 Spectacular Artificial Intelligence (AI) Stock to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 20+ Advantages and Disadvantages of AI | Pros of Artificial Intelligence - Simplilearn - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 1 Surprising Stock Harnessing the Power of Artificial Intelligence (AI) - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks to Buy On the Dip Amid Nasdaq Selloff - Yahoo Finance - March 1st, 2025 [March 1st, 2025]
- Review: Artificial intelligence is shaping the future of diabetes care - News-Medical.Net - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Stock -- a 1,020% Gainer Since Its IPO -- Won't Split Its Stock in 2025. Here's Why - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- A Nobel laureate on the economics of artificial intelligence - MIT Technology Review - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - Nasdaq - March 1st, 2025 [March 1st, 2025]
- Meta Platforms Just Caused This Crucial Artificial Intelligence (AI) Stock to Plummet. Should You Buy the Dip? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Artificial Intelligence - AI Update, February 28, 2025: AI News and Views From the Past Week - MarketingProfs.com - March 1st, 2025 [March 1st, 2025]
- The Ultimate Artificial Intelligence (AI) ETF to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Company Will Split Its Stock in 2025 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Should You Forget Nvidia and Buy 2 Artificial Intelligence (AI) Stocks Instead? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Why Artificial Intelligence Stocks SoundHound AI, IonQ, and C3.ai Are Struggling Today - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- AI Cant Do This Anymore: The Dangers of Artificial Intelligence in Academia - Skidmore News - March 1st, 2025 [March 1st, 2025]
- Whats Next in Artificial Intelligence: Agents that can do more than chatbots - Pittsburgh Post-Gazette - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Yahoo - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Associated Press - February 9th, 2025 [February 9th, 2025]
- 3 Top Artificial Intelligence Stocks to Buy in February - MSN - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Lufkin Daily News - February 9th, 2025 [February 9th, 2025]
- 2 of the Hottest Artificial Intelligence (AI) Stocks on the Planet Can Plunge Up to 94%, According to Select Wall Street Analysts - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- These 2 Stocks Are Leading the Data Center Artificial Intelligence (AI) Trend, but Are They Buys Right Now? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Book Review | Genesis: Artificial Intelligence, Hope, and the Human Spirit - LSE - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence Action Summit In France: Maintaining The Dialogue On Global AI Regulation - Forrester - February 9th, 2025 [February 9th, 2025]
- Is prediction the next frontier for artificial intelligence? - Healthcare IT News - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence in Medicines Market Is Set to Reach $18,119 Million | CAGR of 49.6% - openPR - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Audubon County Advocate Journal - February 9th, 2025 [February 9th, 2025]
- Around and About with Richard McCarthy: Asking AI about itself: Will artificial intelligence ever surpass humankind? - GazetteNET - February 9th, 2025 [February 9th, 2025]
- Will the Paris artificial intelligence summit set a unified approach to AI governanceor just be another conference? - Bulletin of the Atomic... - February 9th, 2025 [February 9th, 2025]
- Apple Stock Jumps on Artificial Intelligence (AI) Driving iPhone Sales. Here's Why It's Not Getting Crushed by the DeepSeek Launch. - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Who will win the race to Artificial General Intelligence? - The Indian Express - February 9th, 2025 [February 9th, 2025]
- Prediction: This Artificial Intelligence (AI) Chip Stock Will Win Big From DeepSeek's Feat - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Prediction: 2 Artificial Intelligence (AI) Stocks That Will Be Worth More Than Nvidia 3 Years From Now - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- State of Louisiana Launches Innovation Brand, Announces Creation of $50 Million Growth Fund and Artificial Intelligence Research Institute - Louisiana... - February 9th, 2025 [February 9th, 2025]
- Using smart technologies and artificial intelligence in food packaging can reduce food waste - Yahoo News Canada - February 9th, 2025 [February 9th, 2025]
- BigBear.ai Wins Department of Defense Contract to Prototype Near-Peer Adversary Geopolitical Risk Analysis for Chief Digital and Artificial... - February 9th, 2025 [February 9th, 2025]
- Should Investors Change Their Artificial Intelligence (AI) Investment Strategy After the DeepSeek Launch? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- 1 Unstoppable Artificial Intelligence (AI) Stock to Buy Before It Punches Its Ticket to the $4 Trillion Club - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Got 10 Years and $1000? These 3 Artificial Intelligence (AI) Stocks Are Set to Soar. - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- 1 Artificial Intelligence (AI) Stock Down 33% to Buy Hand Over Fist, According to Wall Street - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Rihanna Calls Out Use of Artificial Intelligence on Her Voice to Doctor a Clip of Her Speaking - Billboard - February 9th, 2025 [February 9th, 2025]
- 3 Best Artificial Intelligence (AI) Stocks to Buy in February - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Buying This Top Artificial Intelligence (AI) Stock Looks Like a No-Brainer Right Now - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Is Arm Stock a Buy After the Artificial Intelligence (AI) Chip Designer Released Its Quarterly Earnings Report? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Artificial Intelligence, the Academy, And A New Studia Humanitatis - Minding The Campus - February 9th, 2025 [February 9th, 2025]
- The Trump Administrations Artificial Intelligence Rollback Is a Chance to Rethink AI Policy - Ms. Magazine - February 5th, 2025 [February 5th, 2025]
- Workday layoffs: California-based company lays off 1,750 employees, 8.5% of its workforce in favor of artificial intelligence - ABC7 Los Angeles - February 5th, 2025 [February 5th, 2025]
- It can really transform lives: Navigating the ethical landscape of artificial intelligence - WKMG News 6 & ClickOrlando - February 5th, 2025 [February 5th, 2025]
- Legal Restrictions Governing Artificial Intelligence in the Workplace - Law.com - February 5th, 2025 [February 5th, 2025]
- Google drops AI weapons banwhat it means for the future of artificial intelligence - VentureBeat - February 5th, 2025 [February 5th, 2025]
- MPs to scrutinise use of artificial intelligence in the finance sector - ComputerWeekly.com - February 5th, 2025 [February 5th, 2025]
- Catalyzing Change: Innovation and Efficiency through Artificial Intelligence in Contracting - United States Army - February 5th, 2025 [February 5th, 2025]
- STSD to hear cost breakdown, address artificial intelligence in education - The Wellsboro Gazette - February 5th, 2025 [February 5th, 2025]
- OECD activities during the Artificial Intelligence (AI) Action Summit - OECD - February 5th, 2025 [February 5th, 2025]
- Tether Ventures Into Artificial Intelligence With New Application Suite - Bitcoin.com News - February 5th, 2025 [February 5th, 2025]
- Will Artificial Intelligence Kill Acting? Nicholas Cage Thinks It Could - Movieguide - February 5th, 2025 [February 5th, 2025]
- 3 Reasons to Buy This Artificial Intelligence (AI) Stock on the Dip - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- 1 No-Brainer Artificial Intelligence (AI) Stock to Buy With $35 and Hold for the Long Run - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Google renounces its promise not to develop weapons with artificial intelligence - Mezha.Media - February 5th, 2025 [February 5th, 2025]
- DeepSeek Just Changed Generative Artificial Intelligence (AI) Forever. 2 Surprising Winners From Its Innovation. - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare - The BMJ - February 5th, 2025 [February 5th, 2025]
- DeepSeek Just Exposed the Biggest Flaw of the Artificial Intelligence (AI) Revolution - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Artificial Intelligence Is Here: How The Innovative Technology Is Taking Over The Stateline - WREX.com - February 5th, 2025 [February 5th, 2025]
- The Ultimate Artificial Intelligence (AI) Stocks to Buy in 2025 - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- This Magnificent Artificial Intelligence (AI) Stock Has Shot Up Over 175% in Just 3 Months, and It Could Soar Higher in 2025 - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Artificial intelligence is bringing nuclear power back from the dead maybe even in California - CalMatters - February 5th, 2025 [February 5th, 2025]
- Got $5,000? These Are 3 of the Cheapest Artificial Intelligence Stocks to Buy Right Now - The Motley Fool - February 5th, 2025 [February 5th, 2025]
- Compass Capital partners with MIT Sloan School of Management on an artificial intelligence project - ZAWYA - February 5th, 2025 [February 5th, 2025]
- 3 No-Brainer Artificial Intelligence (AI) Stocks to Buy With $500 Right Now - The Motley Fool - February 5th, 2025 [February 5th, 2025]